The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Organically modified silica nanoparticles: A nonviral vector for in vivo gene delivery and expression in the brain
Open accessAbstract
This article reports on the application of organically modified silica (ORMOSIL) nanoparticles as a nonviral vector for efficient in vivo gene delivery. Highly monodispersed, stable aqueous suspension of nanoparticles, surface-functionalized with amino groups for binding of DNA, were prepared and characterized. Stereotaxic injections of nanoparticles, complexed with plasmid DNA encoding for EGFP, into the mouse ventral midbrain and into lateral ventricle, allowed us to fluorescently visualize the extensive transfection of neuronal-like cells in substantia nigra and areas surrounding the lateral ventricle. No ORMOSIL-based toxicity was observed 4 weeks after transfection. The efficiency of transfection equaled or exceeded that obtained in studies using a viral vector. An in vivo optical imaging technique (a fiber-based confocal fluorescent imaging system) provided an effective means to show the retention of viability of the transfected cells. The ORMOSIL-mediated transfections also were used to manipulate the biology of the neural stem/progenitor cells in vivo . Transfection of a plasmid expressing the nucleus-targeting fibroblast growth factor receptor type 1 resulted in significant inhibition of the in vivo incorporation of bromodeoxyuridine into the DNA of the cells in the subventricular zone and the adjacent rostral migratory stream. This in vivo approach shows that the nuclear receptor can control the proliferation of the stem/progenitor cells in this region of the brain. The results of this nanomedicine approach using ORMOSIL nanoparticles as a nonviral gene delivery platform have a promising future direction for effective therapeutic manipulation of the neural stem/progenitor cells as well as in vivo targeted brain therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Synthetic DNA delivery systems
Luo, D., & Saltzman, W. M. (2000) · Nature Biotechnology · doi:10.1038/71889 · Cited by 1,626
Morshead, C. M., Reynolds, B. A., Craig, C. G., McBurney, M. W., Staines, W. A., Morassutti, D., Weiss, S., & van der Kooy, D. (1994) · Neuron · doi:10.1016/0896-6273(94)90046-9 · Cited by 1,403
Lois, C., & Alvarez-Buylla, A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.2074 · Cited by 1,339
Kuhn, H. G., Winkler, J., Kempermann, G., Thal, L. J., & Gage, F. H. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-15-05820.1997 · Cited by 1,208
Poly(ethylenimine) and its role in gene delivery
Godbey, W. T., Wu, K. K., & Mikos, A. G. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00090-5 · Cited by 1,199
Roy, I., Ohulchanskyy, T. Y., Pudavar, H. E., Bergey, E. J., Oseroff, A. R., Morgan, J., Dougherty, T. J., & Prasad, P. N. (2003) · Journal of the American Chemical Society · doi:10.1021/ja0343095 · Cited by 929
Self-citationParkin-deficient Mice Exhibit Nigrostriatal Deficits but Not Loss of Dopaminergic Neurons
Goldberg, M. S., Fleming, S. M., Palacino, J. J., Cepeda, C., Lam, H. A., Bhatnagar, A., Meloni, E. G., Wu, N., Ackerson, L. C., Klapstein, G. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308947200 · Cited by 913
Craig, C., Tropepe, V, Morshead, C., Reynolds, B., Weiss, S., & van der Kooy, D. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-08-02649.1996 · Cited by 752
Prasad, P. N. (2003) · Wiley eBooks · doi:10.1002/0471465380 · Cited by 653
Self-citationA triploblast origin for Myxozoa?
Anderson, C. L., Canning, E. U., & Okamura, B. (1998) · Nature · doi:10.1038/32801 · Cited by 649
Masliah, E., Rockenstein, E., Veinbergs, I., Sagara, Y., Mallory, M., Hashimoto, M., & Mucke, L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211412398 · Cited by 607
Enhancement of transfection by physical concentration of DNA at the cell surface
Luo, D., & Saltzman, W. M. (2000) · Nature Biotechnology · doi:10.1038/78523 · Cited by 541
Maslov, A. Y., Barone, T. A., Plunkett, R. J., & Pruitt, S. C. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4608-03.2004 · Cited by 522
Gritti, A., Frölichsthal-Schoeller, P., Galli, R., Parati, E. A., Cova, L., Pagano, S. F., Bjornson, C. R., & Vescovi, A. L. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-09-03287.1999 · Cited by 522
Prasad, P. N. (2004) · Wiley eBooks · doi:10.1002/0471670251 · Cited by 469
Self-citationRoy, I., Ohulchanskyy, T. Y., Bharali, D. J., Pudavar, H. E., Mistretta, R. A., Kaur, N., & Prasad, P. N. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408039101 · Cited by 457
Self-citationSmart, I. (1961) · Journal of Comparative Neurology · doi:10.1002/cne.901160306 · Cited by 448
Prasad, P. N., & Masters, B. R. (2005) · Journal of Biomedical Optics · doi:10.1117/1.1931672 · Cited by 441
Self-citationRaballo, R., Rhee, J., Lyn-Cook, R., Leckman, J. F., Schwartz, M. L., & Vaccarino, F. M. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-13-05012.2000 · Cited by 420
Biomédical applications of nanotechnology — implications for drug targeting and gene therapy
Davis, S. S. (1997) · Trends in Biotechnology · doi:10.1016/s0167-7799(97)01036-6 · Cited by 416
Direct Evidence for Homotypic, Glia-Independent Neuronal Migration
Wichterle, H., García-Verdugo, J. M., & Alvarez-Buylla, A. (1997) · Neuron · doi:10.1016/s0896-6273(00)80317-7 · Cited by 414
Morshead, C., & van der Kooy, D. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-01-00249.1992 · Cited by 388
Kneuer, C., Sameti, M., Bakowsky, U., Schiestel, T., Schirra, H., Schmidt, H., & Lehr, C.-M. (2000) · Bioconjugate Chemistry · doi:10.1021/bc0000637 · Cited by 359
Schizophrenia: from phenomenology to neurobiology
Wong, A. H. C., & Van Tol, H. H. M. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(03)00035-6 · Cited by 280
Silica nanoparticles modified with aminosilanes as carriers for plasmid DNA
Kneuer, C., Sameti, M., Haltner, E. G., Schiestel, T., Schirra, H., Schmidt, H., & Lehr, C.-M. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00435-4 · Cited by 276
Ueno, H., Gunn, M., Dell, K., Tseng, A., & Williams, L. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45969-8 · Cited by 266
Bioconjugated Nanoparticles for DNA Protection from Cleavage
He, X.-X., Wang, K., Tan, W., Liu, B., Lin, X., He, C., Li, D., Huang, S., & Li, J. (2003) · Journal of the American Chemical Society · doi:10.1021/ja034450d · Cited by 266
No evidence for new dopaminergic neurons in the adult mammalian substantia nigra
Frielingsdorf, H., Schwarz, K., Brundin, P., & Mohapel, P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401229101 · Cited by 251
Importin β–Mediated Nuclear Import of Fibroblast Growth Factor Receptor
Reilly, J. F., & Maher, P. A. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.6.1307 · Cited by 231
Stachowiak, M. K., Fang, X., Myers, J. M., Dunham-Ems, S. M., Berezney, R., Maher, P. A., & Stachowiak, E. K. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10606 · Cited by 135
Self-citationStachowiak, E. K., Fang, X., Myers, J. A., Dunham-Ems, S. M., & Stachowiak, M. K. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01624.x · Cited by 109
Self-citationShin, D., Korada, S., Raballo, R., Shashikant, C. S., Simeone, A., Taylor, J. R., & Vaccarino, F. M. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.5285-03.2004 · Cited by 100
Hu Peng, Myers, J. M., Fang, X., Stachowiak, E. K., Maher, P. A., Martins, G. G., Popescu, G., Berezney, R., & Stachowiak, M. K. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00833.x · Cited by 91
Self-citationControl of CREB-binding Protein Signaling by Nuclear Fibroblast Growth Factor Receptor-1
Fang, X., Stachowiak, E. K., Dunham-Ems, S. M., Klejbor, I., & Stachowiak, M. K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504400200 · Cited by 80
Self-citationIdentifying and manipulating neuronal stem cells
Cattaneo, E. F., & McKay, R. D. G. (1991) · Trends in Neurosciences · doi:10.1016/0166-2236(91)90158-q · Cited by 62
Tooyama, I., McGeer, E. G., Kawamata, T., Kimura, H., & McGeer, P. L. (1994) · Brain Research · doi:10.1016/0006-8993(94)91378-1 · Cited by 62
Gene Therapy for Central Nervous System Injury: The Use of Cationic Liposomes: An Invited Review
Yang, K., Clifton, G. L., & Hayes, R. L. (1997) · Journal of Neurotrauma · doi:10.1089/neu.1997.14.281 · Cited by 55
Horbinski, C., Stachowiak, E. K., Chandrasekaran, V., Miuzukoshi, E., Higgins, D. M., & Stachowiak, M. K. (2001) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00657.x · Cited by 49
Self-citationShin, J., London, J., LePecheur, M., Höger, H., Pollak, D. D., & Lübec, G. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.05.019 · Cited by 42
Neuroprotection for Parkinson's disease using viral vector-mediated delivery of GDNF
McBride, J. L., & Kordower, J. H. (2002) · Progress in brain research · doi:10.1016/s0079-6123(02)38091-9 · Cited by 34
Hanneken, A. M. (2001) · FEBS Letters · doi:10.1016/s0014-5793(00)02409-1 · Cited by 32
Geller, A. I., Yu, L. C., Wang, Y., et al. (1997) · Experimental Neurology · doi:10.1006/exnr.1996.6394 · Cited by 29
Cancer risk prompts US to curb gene therapy
Check, E. (2003) · Nature · doi:10.1038/422007a · Cited by 22
Gene therapy for cerebral vascular disease: update 2003
Toyoda, Ḱ., Chu, Y., & Heistad, D. D. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705217 · Cited by 19
Novel therapeutic directions for Parkinson's disease
Fisher, L. J., & Gage, F. H. (1995) · Molecular Medicine Today · doi:10.1016/s1357-4310(95)91888-4 · Cited by 11
Gene transfer into the central nervous system using herpes simplex virus-1 vectors.
Tabbaa, S., Goulah, C. C., Tran, R. K., Lis, A., Korody, R., Stachowski, B., Horowitz, J. M., Torres, G., Stachowiak, E. K., Bloom, D. C., et al. (2000) · PubMed · Cited by 10
Self-citationRadical directions in Parkinson's disease
Fisher, L. J., & Gage, F. H. (1995) · Nature Medicine · doi:10.1038/nm0395-201 · Cited by 9
Cited by
Ghosh Chaudhuri, R., & Paria, S. (2012) · Chemical Reviews · doi:10.1021/cr100449n · Cited by 3,614
Nonviral vectors for gene delivery
Mintzer, M. A., & Simanek, E. E. (2009) · Chemical Reviews · doi:10.1021/cr800409e · Cited by 2,366
Gold Nanoparticles for Biology and Medicine
Giljohann, D. A., Seferos, D. S., Daniel, W. L., Massich, M. D., Patel, P. C., & Mirkin, C. A. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200904359 · Cited by 2,356
Oligonucleotide-Modified Gold Nanoparticles for Intracellular Gene Regulation
Rosi, N. L., Giljohann, D. A., Thaxton, C. S., Lytton-Jean, A. K. R., Han, M. S., & Mirkin, C. A. (2006) · Science · doi:10.1126/science.1125559 · Cited by 1,988
Mesoporous silica nanoparticles for drug delivery and biosensing applications
Slowing, I. I., Trewyn, B. G., Giri, S., & Lin, V. S. ‐. (2007) · Advanced Functional Materials · doi:10.1002/adfm.200601191 · Cited by 1,699
Metadata
- Authors
- Bharali, D. J., Klejbor, I., Stachowiak, E. K., Dutta, P., Roy, I., Kaur, N., Bergey, E. J., Prasad, P. N., & Stachowiak, M. K.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2005-07-28
- Volume
- 102
- Issue
- 32
- Pages
- 11539-11544
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2006986838
- Cited by
- 622
- References
- 47
- FWCI
- 9.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.